Transforming Molecular Diagnostics

Rapid Detection of Infectious Diseases

Rapid and comprehensive detection of pathogens is an important strategy in reducing the spread of infectious disease. Our EasyScreen™ Detection Kits identify a larger number of pathogen targets in a shorter time frame than conventional methods.

Efficient Workflow

Traditional techniques for identifying viral, bacterial and protozoan pathogens require a high degree of knowledge and can take days to get a result. Our EasyScreen™ Detection Kits replace these methodologies with a single efficient workflow that requires less training, staff and hands-on-time, and gives a result in under 5 hours.


The Genetic Signatures GS1 platform is a high-throughput bench top platform that performs both nucleic acid extraction and automated 384-well PCR set-up for the entire EasyScreen™ range. Our EasyScreen™ Detection Kits are also compatible with most existing automated nucleic acid extraction and real-time PCR instruments.

Standardised Sample Processing

Our EasyScreen™ Sample Processing Kits offer streamlined preparation of nucleic acids direct from the primary specimen. Our sample processing method is common for all specimen types leading to workflow efficiencies and standardised results between laboratories.

3base™ Multiplex Technology

Our 3base™ technology forms the basis of the EasyScreen™ Detection Kits. 3base™ allows for simpler design of molecular assays facilitating the simultaneous detection of multiple targets. 3base™ is compatible with both RNA and DNA targets.

Product Pipeline

Genetic Signatures has a number of new detection kits in development. All new products follow a defined development and commercialisation process comprised of (i) Experimental Analytical Validation, and (ii) Clinical and Regulatory Validation prior to release.

Genetic Signatures exhibiting and poster presentation at the annual Australian Society of Microbiology (ASM) meeting, 1-4 July, South Brisbane, Queensland

| Latest News | No Comments

Genetic Signatures are exhibiting at the Australian Society for Microbiology Annual Scientific Meeting (ASM) 2018 in South Brisbane, Queensland on 1-4 July 2018. Held at the Brisbane Convention and Exhibition…

Genetic Signatures exhibiting ASM Microbe 2018 Atlanta, Georgia US, 7-11 June

| Latest News | No Comments

Genetic Signatures are exhibiting at the ASM Microbe in Atlanta, Georgia, United States, 07-11 June 2018. ASM Microbe 2018 connecting scientists with their science–showcases the best microbial sciences in the…

Genetic Signatures presenting at 12th International Symposium on Molecular Diagnostics (ISMD) May 31- June 02, 2018 Graz, Austria.

| Latest News | No Comments

Led by scientists engaged in research and physicians involved with patient care, this international symposium will provide a meaningful exchange of ideas dealing with molecular diagnostics. Discussion of current topics…

Genetic Signatures (ASX: GSS) Investor Presentation, May 2018

| ASX Announcements, Latest News | No Comments

Genetic Signatures Limited (ASX: GSS) Investor Presentation, May 2018 Click here to read more